ANGELA HOLSEY: Open Payments
NPI 1750665667 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,252 in 103 payments from 11 companies in 2025. Trend: 2023 $949 · 2024 $1,705 · 2025 $2,252
Food & beverage: $2,252
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 20 | $494 |
| ABBVIE INC. | 25 | $478 |
| Ardelyx, Inc. | 13 | $268 |
| Madrigal Pharmaceuticals | 4 | $252 |
| Phathom Pharmaceuticals, Inc. | 11 | $237 |
| PFIZER INC. | 14 | $178 |
| Aimmune Therapeutics, Inc. | 8 | $150 |
| Janssen Scientific Affairs, LLC | 1 | $67 |
| Lilly USA, LLC | 3 | $59 |
| Janssen Biotech, Inc. | 3 | $51 |
Products named: XIFAXAN, IBSRELA, REZDIFFRA, VOQUEZNA, SKYRIZI, TREMFYA, ZENPEP, VELSIPITY.
Industry payments across GA — which companies pay providers there.
